Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 736 AL 750

Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review

Kulkarni AD, Vanjari YH, Sancheti KH, Belgamwar VS, Surana SJ, Pardeshi CV.

J Drug Target. 2015;23(9):775-88. doi: 10.3109/1061186X.2015.1020809. Epub 2015 Mar 11.

Zooming in on the small: the plasticity of striatal dendritic spines in L-DOPA-induced dyskinesia

Fieblinger T, Cenci MA.

Mov Disord. 2015 Apr;30(4):484-93. doi: 10.1002/mds.26139. Epub 2015 Mar 11.

Paraphilias and paraphilic disorders in Parkinson's disease: A systematic review of the literature

Solla P, Bortolato M, Cannas A, Mulas CS, Marrosu F.

Mov Disord. 2015 Apr 15;30(5):604-13. doi: 10.1002/mds.26157. Epub 2015 Mar 11.

A heme oxygenase-1 transducer model of degenerative and developmental brain disorders

Schipper HM, Song W.

Int J Mol Sci. 2015 Mar 9;16(3):5400-19. doi: 10.3390/ijms16035400.

On visual hallucinations and cortical networks: a trans-diagnostic review

Carter R, Ffytche DH.

J Neurol. 2015 Jul;262(7):1780-90. doi: 10.1007/s00415-015-7687-6. Epub 2015 Mar 13.

Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1

van der Merwe C, Jalali Sefid Dashti Z, Christoffels A, Loos B, Bardien S.

Eur J Neurosci. 2015 May;41(9):1113-25. doi: 10.1111/ejn.12872. Epub 2015 Mar 11.

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease

d'Anglemont de Tassigny X, Pascual A, López-Barneo J.

Front Neuroanat. 2015 Feb 13;9:10. doi: 10.3389/fnana.2015.00010. eCollection 2015.

Orthostatic hypotension in Parkinsonism: What is it and how can we treat it?

Fox SH, Marras C.

Mov Disord. 2015 Apr 15;30(5):601-3. doi: 10.1002/mds.26179. Epub 2015 Mar 11.

The EIF4G1 gene and Parkinson's disease

Deng H, Wu Y, Jankovic J.

Acta Neurol Scand. 2015 Aug;132(2):73-8. doi: 10.1111/ane.12397. Epub 2015 Mar 13.

Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study

Postuma RB, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R, Miyamoto T, Oertel W, Dauvilliers Y, Ju YE, Puligheddu M, Sonka K, Pelletier A, Santamaria J, Frauscher B, Leu-Semenescu S, Zucconi M, Terzaghi M, Miyamoto M, Unger MM, Carlander B, Fantini ML, Montplaisir JY.

Ann Neurol. 2015 May;77(5):830-9. doi: 10.1002/ana.24385. Epub 2015 Mar 13.

Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease

Murakami Y, Kakeda S, Watanabe K, Ueda I, Ogasawara A, Moriya J, Ide S, Futatsuya K, Sato T, Okada K, Uozumi T, Tsuji S, Liu T, Wang Y, Korogi Y.

AJNR Am J Neuroradiol. 2015 Jun;36(6):1102-8. doi: 10.3174/ajnr.A4260. Epub 2015 Mar 12.

Digital Health Revolution: Is it Time for Affordable Remote Monitoring for Parkinson's Disease?

Papapetropoulos S, Mitsi G, Espay AJ.

Front Neurol. 2015 Feb 26;6:34. doi: 10.3389/fneur.2015.00034. eCollection 2015.

A long-term study of istradefylline safety and efficacy in patients with Parkinson disease

Kondo T, Mizuno Y; Japanese Istradefylline Study Group.

Clin Neuropharmacol. 2015 Mar-Apr;38(2):41-6. doi: 10.1097/WNF.0000000000000073.

Pet killing as a manifestation of impulse control disorder secondary to pramipexol

Micheli F, Pellene A, Arcushin D, Calzinari A, Farret MS.

Clin Neuropharmacol. 2015 Mar-Apr;38(2):55-6. doi: 10.1097/WNF.0000000000000074.

Parkinson's disease and enhanced inflammatory response

Stojkovska I, Wagner BM, Morrison BE.

Exp Biol Med (Maywood). 2015 Nov;240(11):1387-95. doi: 10.1177/1535370215576313. Epub 2015 Mar 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias